Institutional members access full text with Ovid®

Share this article on:

Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population

Xie, Cuia; Wang, Zeng Chana; Liu, Xiao Fengb; Wang, Lia; Yang, Mao Shenga,c

doi: 10.1097/YPG.0b013e32834acc85
Original Articles

Objective Many studies have suggested that certain types of lipids such as phospholipids, fatty acids, and cholesterols are involved in the pathology of nervous system diseases. Lipoprotein lipase (LPL), as the key enzyme of triglyceride hydrolysis, is expressed in the brain regions functionally relevant to learning, memory, and other cognitive functions. In addition, both genome-wide linkage and association studies in schizophrenia have implicated the chromosome 8p22 region, in which the LPL gene is located. Therefore, LPL is an attractive candidate gene for schizophrenia and we tested this hypothesis in a case–control sample.

Methods In this study, we investigated allele and genotype frequencies distributions of nine single nucleotide polymorphisms (SNPs) within the LPL gene in Han Chinese patients with schizophrenia (n=319) and healthy controls (n=575).

Results Significant differences were detected between case and control groups in the frequencies of rs253 alleles [odds ratio (OR): 1.74; 95% confidence interval (CI): 1.43–2.11; P=3.21×10−8] and genotypes (OR: 3.08; 95%CI: 2.07–4.56; global P=7.88×10−9), respectively. Interestingly, this association was observed only in the male (P=5.87×10−9 for allele; P=1.79×10−11 for genotype) and not in the female samples (P>0.05). After correcting for multiple testing, the above association remains to be significant (P c<1×10−6). These results suggest that rs253 C allele and CC genotype confer risk for schizophrenia in men.

Conclusion Our study lends support to the potential role of lipid metabolism in schizophrenia and further investigations are warranted.

aLaboratory of Disorder Genes and Pharmacogenomics Research Center, Institute of Life Sciences, Chongqing University of Medical Sciences

bDivision of Periodicals, Chongqing Medical University Library

cDepartment of Pharmacology, College of Pharmacy, Chongqing University of Medical Sciences, Chongqing, P.R. China

Correspondence to Professor Mao Sheng Yang, Laboratory of Disorder Genes and Pharmacogenomics Research Center, Institute of Life Sciences, Chongqing University of Medical Sciences, P.O. Box 380, 1 Yi Xue Yuan Road, Chongqing 400016, P.R. China Tel: +86 23 6848 5808; fax: +86 23 6848 5111; e-mail:

Cui Xie and Zeng Chan Wang contributed equally to this study.

Received August 16, 2010

Accepted June 8, 2011

© 2011 Lippincott Williams & Wilkins, Inc.